Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
XLV
XLV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XLV News
UNH vs. HUM: Which Insurance Stock Offers Greater Potential Following CMS's Reversal of Wall Street's Major Medicare Rate Concern?
Apr 07 2026
stocktwits
Pharma Stocks Pfizer and GSK Provide Safe Investment Options Amid Market Uncertainty: Charts
Mar 30 2026
Barron's
Implications of Q1 Earnings for the S&P 500's Upward Trend
Mar 24 2026
Marketbeat
Investors Should Adopt a Defensive Strategy: Offload Staples and Invest in Healthcare.
Feb 26 2026
Barron's
5 Stocks and ETFs to Protect Your Portfolio Amid Market Fluctuations
Feb 09 2026
Marketbeat
Pharma Stocks on the Verge of a Breakthrough: Earnings May Propel Them Forward.
Jan 28 2026
Barron's
Three Previous Stock Selections Subtly Indicate Buy Opportunities Once More
Jan 28 2026
Barron's
UnitedHealth Is Dragging Down the Dow, While the Broader Market Remains Stable.
Jan 27 2026
Barron's
UnitedHealth Drags Down the Dow, But the Broader Stock Market Remains Stable.
Jan 27 2026
Barron's
Hold Off on Pursuing Semiconductors for Now: Insights from Charts on Entry Points for Three Chip Stocks.
Jan 16 2026
Barron's
TG Therapeutics Shares Surge as Briumvi Success Revives Bullish Outlook: Goldman Sachs Predicts 32% Upside Potential
Jan 15 2026
stocktwits
Bristol Myers and Two Additional Stocks Recommended for Purchase Based on Technical Indicators
Jan 14 2026
Barron's
Biotech and Pharma Shares Drop as Investors Shift Focus to Energy Sector
Jan 05 2026
Barron's
Adaptive Biotechnologies Leads Life Sciences Tools and Services Stocks in Year-to-Date Performance
Dec 23 2025
SeekingAlpha
Regencell Bioscience Leads Pharma Stocks in Year-to-Date Performance
Dec 22 2025
SeekingAlpha
Abivax Leads Biotechnology Stocks in Year-to-Date Performance
Dec 22 2025
SeekingAlpha
Show More News
